Diagnostic Accuracy of Extracellular versus Hepatobiliary Contrast-enhanced MRI in LI-RADS Nonradiation Treatment Response Algorithm Version 2024

Extracellular contrast agent MRI demonstrated higher sensitivity than hepatobiliary contrast agent MRI for detecting viable hepatocellular carcinoma in patients who underwent locoregional treatment when ancillary features were not applied, whereas using ancillary features resulted in comparable sensitivities between groups.